PRO15 ORPHAN DRUG METHODOLOGY CHALLENGES IN THE DANISH HTA PROCESS - MEDICINRAADET AND THE HURDLES TO SHOWING CLINICAL BENEFIT IN SMALL PATIENT POPULATIONS
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2346
https://www.valueinhealthjournal.com/article/S1098-3015(19)34724-2/fulltext
Section Title :
Section Order :
12047
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34724-2&doi=10.1016/j.jval.2019.09.2346